Trials / Unknown
UnknownNCT04308343
The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to : 1. Use of the aromatase inhibitor( letrozole) for the treatment of ectopic pregnancy compared to methotrexate. 2. Use of the Gnrh antagonist for the treatment of ectopic pregnancy compared to methotrexate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methotrexate | Drugs to treat undisturbed ectopic pregnancies |
| DRUG | Letrozole | Drugs to treat undisturbed ectopic pregnancies |
| DRUG | cetrotide | Drugs to treat undisturbed ectopic pregnancies |
Timeline
- Start date
- 2020-03-30
- Primary completion
- 2022-03-01
- Completion
- 2022-09-01
- First posted
- 2020-03-16
- Last updated
- 2020-03-16
Source: ClinicalTrials.gov record NCT04308343. Inclusion in this directory is not an endorsement.